USFDA Reports Multiple Drug Recalls by Major Indian Pharma Firms Over Quality Concerns
AI-Generated Summary
Several prominent Indian pharmaceutical companies, including Glenmark, Granules India, Sun Pharma, Zydus, and Unichem, are recalling various medicines from the U.S. market, according to the latest USFDA Enforcement Report. These recalls stem from manufacturing issues such as gritty texture, impurities, degradation, and labeling errors, leading to Class I, II, and III classifications. The actions underscore ongoing regulatory scrutiny and quality control challenges within the global pharmaceutical supply chain.
In a nutshell
These widespread recalls highlight the critical importance of stringent quality control and regulatory compliance for pharmaceutical manufacturers operating in the U.S. market. For industry stakeholders, these incidents serve as a reminder of the continuous oversight by the USFDA and the potential impact on brand reputation and market access.
Source: Lokmat Times
